PHOENIX, May 24, 2016 (GLOBE NEWSWIRE) — Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced that it has successfully completed its Phase 1/Phase 2 safety and pharmacokinetic (PK) study in pediatric subjects with treatment-resistant epilepsy.Continue reading
Category Archives: AZBio News
The Fostering Innovation Act Passes in the U.S. House of Representatives
Sinema, Fitzpatrick Jobs Bill Passes House
Revolutionary organ-on-a-chip device mimics human gut action
Pioneering research tool developed at UA College of Medicine – PhoenixContinue reading
Arizona Governor Ducey Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines
Communication Important for Patients and PhysiciansContinue reading
The Michael J. Fox Foundation for Parkinson’s Research Joins Multinational Critical Path for Parkinson’s Consortium
Consortium, led by Parkinson’s UK and the Critical Path Institute, aggregates and analyzes study data to develop a model for quantitative characterization of Parkinson’s progression. This asset would enrich the design of trials for novel therapies. The Consortium will work with international regulators for acceptance of a quantitative model to streamline review processes.Continue reading
AZBio Watch List- The Final Tally
The Arizona Legislature has adjourned Sine Die as of May 7th, 2016 5:45 A.M.
Here is the final tally for the 2016 Legislative SessionContinue reading
Genentech and Ventana Get FDA Approval on Treatment for Bladder Cancer
The U.S. Food and Drug Administration approved Tecentriq (atezolizumab) on May 18, 2018 to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.
FDA also approved the Ventana PD-L1 (SP142) assay to detect PD-L1 protein expression levels on patients’ tumor-infiltrating immune cells and help physicians determine which patients may benefit most from treatment with Tecentriq..
Arizonans advocating for a more accurate test for Lyme Disease
Focus On Lyme executive director to speak at Capitol Hill science forum. Arizona-based group advocates for a definitive test for Lyme disease being developed by TGenContinue reading
Tucson’s CTX Technology to Collaborate with Zomedica
Zomedica Announces Joint Research Collaboration with CTX Technology, Inc.Continue reading
ASU, White House to investigate mysteries of the microbiome
The White House Office of Science and Technology Policy (OSTP) announced today a new National Microbiome Initiative (NMI) to foster the integrated study of microbiomes across different ecosystems.Continue reading